BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5463059)

  • 21. The effect of fat-rich diets, due to their high sucroglyceride content, on rat liver.
    Tudisco R
    Arzneimittelforschung; 1967 Mar; 17(3):350-3. PubMed ID: 5631225
    [No Abstract]   [Full Text] [Related]  

  • 22. The hypolipemic properties of 2-acetoamidoethyl (p-chlorophenyl) (m-trifluoromethylphenoxy)acetate in the rat.
    Gilfillan JL; Hunt VM; Huff JW
    Proc Soc Exp Biol Med; 1971 Apr; 136(4):1274-6. PubMed ID: 5554475
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the mode of action of clofibrate: effects on hormone-induced changes in plasma free fatty acids, cholesterol, phospholipids and total esterified fatty acids in rats and dogs.
    Barrett AM; Thorp JM
    Br J Pharmacol Chemother; 1968 Feb; 32(2):381-91. PubMed ID: 4296427
    [No Abstract]   [Full Text] [Related]  

  • 24. Microbodies in experimentally altered cells. VI. Thyroxine displacement from plasma proteins and clofibrate effect.
    Azarnoff DL; Svoboda DJ
    Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):386-93. PubMed ID: 4397540
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of dietary fats with different essential fatty acid configurations on plasma and liver cholesterol in rats.
    Yamamoto I; Sugano M; Kadota A; Sato Y; Wada M
    J Biochem; 1969 Nov; 66(5):685-91. PubMed ID: 5390924
    [No Abstract]   [Full Text] [Related]  

  • 26. Potentiating of lipid-lowering activity of clofibrate by combining with low doses of 3-pyridylcarbinol in rats.
    Simane Z; Nowak H
    Atherosclerosis; 1974; 20(3):447-52. PubMed ID: 4429617
    [No Abstract]   [Full Text] [Related]  

  • 27. Hypolipidaemic properties of a new tetralin derivative (CIBA 13,437-Su).
    Hess R; Bencze WL
    Experientia; 1968 May; 24(5):418-9. PubMed ID: 5674960
    [No Abstract]   [Full Text] [Related]  

  • 28. Blood lipids and lipoproteins in atherogenesis.
    Brown DF
    Am J Med; 1969 May; 46(5):691-704. PubMed ID: 4892338
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of nicotinic acid on the serum lipids of normal and of thyroidectomized dogs.
    Grande F
    Metabolism; 1966 Jul; 15(7):661-71. PubMed ID: 5918362
    [No Abstract]   [Full Text] [Related]  

  • 30. Anti-hypercholesterolemic effect of a sulfur containing amino acid, S-methyl-L-cysteine sulfoxide, isolated from cabbage.
    Fujiwara M; Itokawa Y; Uchino H; Inoue K
    Experientia; 1972 Mar; 28(3):254-5. PubMed ID: 5026420
    [No Abstract]   [Full Text] [Related]  

  • 31. The effects of clofibrate on acetyl-CoA carboxylase activity in hepatocytes.
    Harkins JB; Yates RD
    Z Zellforsch Mikrosk Anat; 1971; 119(3):321-5. PubMed ID: 5569050
    [No Abstract]   [Full Text] [Related]  

  • 32. The hypolipidemic effect of a new ACAT inhibitor, VULM 1457, in diabetic-hypercholesterolaemic rats.
    Adameová A; Kuzelová M; Faberová V; Svec P
    Pharmazie; 2005 Sep; 60(9):714-5. PubMed ID: 16222877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antilipaemic effect of nicotinamide.
    Dalton C
    Nature; 1967 Nov; 216(5117):825. PubMed ID: 4229354
    [No Abstract]   [Full Text] [Related]  

  • 34. [Influence of Atromid-S and high-fat diet on lipids and lipolysis in rat tissues and serum].
    Grafnetter D; Mrhová O; Janda J
    Cas Lek Cesk; 1970 May; 109(20):433-9. PubMed ID: 5429476
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmacology of probucol. I].
    Donatelli L
    Clin Ter; 1984 Mar; 108(5):367-88. PubMed ID: 6232074
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cholesterol and lipid lowering effects and vascular action of p-chlororphenoxy-alpha-isobutyrate of 3-hydroxymethyl-pyridine-hydrochloric acid (clofinol)].
    Marmo E; Caputi AP; Vacca C; Imperatore A; Cataldi S
    Clin Ter; 1974 Mar; 68(6):519-67. PubMed ID: 4831379
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experimental analysis of the interactions between heparin and a duodenal heparinoid].
    Marmo E; Lampa E; Vacca C; Rossi F; Spadaro R; Sannino A
    Arch Sci Med (Torino); 1975; 132(3):83-115. PubMed ID: 56927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of miscleron on serum lipid parameters in atherosclerosis induced by cholesterol.
    Virág S; Dénes R; Pozsonyi T; Tury K
    Ther Hung; 1971; 19(4):148-9. PubMed ID: 4336261
    [No Abstract]   [Full Text] [Related]  

  • 39. [Lipid changes produced during the production of non-occlusive cardiac necroses in rats using a thrombogenic diet and Na2HPO4].
    Savoie LL; Lepage M; Moorjani S; Lupien PJ
    Union Med Can; 1973 Jul; 102(7):1457-64. PubMed ID: 4794513
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevention of CeCl3-induced hepatotoxicity by hypolipidemic compounds.
    Tuchweber B; Salas M
    Arch Toxicol; 1978 Dec; 41(3):223-32. PubMed ID: 736793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.